Search research articles
Contact Us
Filters
Showing results (331-340 of 519) with videos related to
Page
of 52
Sort By:
British Journal of Haematology
|
November 5, 2011
Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system
Holger W Auner, Jiri Pavlu, Richard Szydlo, et al.
Environmental Research
|
May 14, 2021
Pesticide use and kidney function among farmers in the Biomarkers of Exposure and Effect in Agriculture study
Joseph J Shearer, Dale P Sandler, Gabriella Andreotti, et al.
British Journal of Haematology
|
February 7, 2020
Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
Marion Eveillard, Even Rustad, Mikhail Roshal, et al.
Blood
|
October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy
David G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.
Cytometry. Part B, Clinical Cytometry
|
September 15, 2010
Prevalence of monoclonal B-cell lymphocytosis: a systematic review
Youn K Shim, Dannie C Middleton, Neil E Caporaso, et al.
Leukemia & Lymphoma
|
December 3, 2016
Proteomic profiling in plasma cell disorders: a feasibility study
Sham Mailankody, Sean M Devlin, Neha Korde, et al.
Blood
|
January 31, 2009
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren, Robert A Kyle, Ruth M Pfeiffer, et al.
Haematologica
|
September 3, 2021
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
Urvi A Shah, Sæmundur Rögnvaldsson, Andriy Derkach, et al.
Leukemia & Lymphoma
|
May 26, 2017
Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma
Dalia Abdel-Raouf Salem, Neha Korde, David J Venzon, et al.
Radiology
|
April 8, 2020
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging
Gary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, et al.
Page
of 52
Search research articles
Search
Showing results (331-340 of 519) with videos related to
Sort By:
Page
of 52
British Journal of Haematology
|
November 5, 2011
Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system
Holger W Auner, Jiri Pavlu, Richard Szydlo, et al.
Environmental Research
|
May 14, 2021
Pesticide use and kidney function among farmers in the Biomarkers of Exposure and Effect in Agriculture study
Joseph J Shearer, Dale P Sandler, Gabriella Andreotti, et al.
British Journal of Haematology
|
February 7, 2020
Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
Marion Eveillard, Even Rustad, Mikhail Roshal, et al.
Blood
|
October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy
David G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.
Cytometry. Part B, Clinical Cytometry
|
September 15, 2010
Prevalence of monoclonal B-cell lymphocytosis: a systematic review
Youn K Shim, Dannie C Middleton, Neil E Caporaso, et al.
Leukemia & Lymphoma
|
December 3, 2016
Proteomic profiling in plasma cell disorders: a feasibility study
Sham Mailankody, Sean M Devlin, Neha Korde, et al.
Blood
|
January 31, 2009
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren, Robert A Kyle, Ruth M Pfeiffer, et al.
Haematologica
|
September 3, 2021
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
Urvi A Shah, Sæmundur Rögnvaldsson, Andriy Derkach, et al.
Leukemia & Lymphoma
|
May 26, 2017
Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma
Dalia Abdel-Raouf Salem, Neha Korde, David J Venzon, et al.
Radiology
|
April 8, 2020
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging
Gary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, et al.
Page
of 52